Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: Relationship with the occurrence of acute graft-versus-host disease

Transplantation

Volumn 63, Issue 9, 1997, Pages 1307-1313

  Carayol, Géraldine ^a   Bourhis, Jean Henri ^a   Guillard, Maryvonne ^a   Bosq, Jacques ^a   Pailler, Christine ^a   Castagna, Luca ^a   Vernant, Jean Paul ^b   Pico, José Luis ^a   Hayat, Marcel ^a   Chouaib, Salem ^a   Caignard, Anne ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; GRAFT VERSUS HOST REACTION; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOPSY; BONE MARROW TRANSPLANTATION; CHILD; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TH1 CELLS; TH2 CELLS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030971575     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00019     Document Type: Article

References (33)

1. Marmont AM, Horowitz MM, Gale RP, et al. T cell depletion of HLA-identical transplants in leukemia. Blood 1991; 8: 2120.
2. Ferrara JLM. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 1993; 5: 794.
3. Jadus MR, Wepsic HT. The role of cytokines in graft-versus-host reaction and disease. Bone Marrow Transplant 1992; 10: 1.
4. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 136: 111.
5. Croft M, Carter L, Swain SL, et al. Generation of antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1995; 180: 1715.
6. Folder DH, Kurasawa K, Husebeck A, et al. Cells of the Th2 cytokine phenotype prevent LPS-induced lethality during graft-versus-host reaction. J Immunol 1994; 152: 1004.
7. + T cells. J Immunol 1995; 155: 2396.
8. Imamura M, Hashino S, Kobayashi S, et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant 1994; 13: 745.
9. Robinet E, Ibrahim A, Truneh A, et al. Serum levels and receptor expression of tumor necrosis factor-α following allogeneic transplantation and autologous bone marrow transplantation. Transplantation 1992; 53: 574.
10. Chasty RC, Lamb WR, Gallati H, Roberts TE, Brenchley PE, Yin JA. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993; 12: 331.
11. Rowbottom AW, Richies PG, Downie C, Hobbs JR. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 635.
12. Legrès LG, Pochon F, Barray M, Heinrich PC, Delain E. Human α2-macroglobulin as a cytokine-binding plasma protein: a study with rh-interleukin-1β and rh-interleukin-6. Ann N Y Acad Sci 1994; 737: 439.
13. Legrès LG, Pochon F, Barray M, Gay F, Chouaib S, Delain E. Evidence for the binding of a biologically active interleukin-2 to human α2-macroglobulin. J Biol Chem 1995; 270: 8381.
14. Bendtzen K, Sveson M, Johnson V, Hippe E. Autoantibodies to cytokines: friends or foes? Immunol Today 1990; 11: 167.
15. Pannetier C, Delassus S, Darche S, Saucier C, Kourilsky P. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res 1993; 21: 577.
16. Delassus S, Coutinho GC, Saucier C, Darche C, Kourilsky P. Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol 1994; 152: 2411.
17. Josien R, Pannetier C, Douillard P, et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 1995; 60: 1131.
18. Tartour E, Gey A, Sastre-Garau X, et al. Analysis of interleù kin-6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin-6 gene expression in invasive carcinoma. Cancer Res 1994; 54: 6243.
19. Holter W, Kalthoff FS, Majdic O, Knapp W. Interleukin-4 production by the malignant cell line HUT78. Lymphokine Cytokine Res 1993; 12: 33.
20. Tanaka J, Imamura M, Kasai M, Sakurada K, Miyazaki T. Cytokine gene expression after allogeneic bone marrow transplantation [Review]. Leuk Lymphoma 1995; 16: 413.
21. Roy J, Blazar BR, Ochs L, Weisdorf DJ. The tissue expression of cytokines in human acute cutaneous graft-versus-host disease. Transplantation 1995; 60: 343.
22. Abhyankar S, Gilliand DG, Ferrara JL. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft-versus-host disease to minor histocompatibility antigens. Transplantion 1993; 56: 1518.
23. Xun CQ, Thompson JS, Jennings C, Brown SA, Widmer MB. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2 incompatible transplanted SCID mice. Blood 1994; 83: 2360.
24. Fowler DH, Kurasawa K, Smith R, Eckaus MA, Gress RE. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994; 84: 3540.
25. Krenger W, Snyder KM, Byon JC, Falzarano G, Ferrara JL. Polarized type 2 alloreactive CD4 and CD8 donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 1995; 155: 585.
26. + lymphoid engraftment. J Immunol 1994; 152: 1004.
27. Baker KS, Allen RD, Roths JB, Sidman CL. Kinetic and organ-specific patterns of cytokine expression in acute graft-versus-host disease. Bone Marrow Transplant 1995; 15: 595.
28. Tanaka J, Imamura M, Kasai M, et al. Cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transcripts as a predictive method for transplantation-related complications. Br J Haematol 1994; 87: 415.
29. Dickinson AM, Sviland L, Hamilton PJ, et al. Cytokine involvement in predicting clinical graft versus host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 65.
30. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host disease. Eur J Immunol 1993; 23: 333.
31. Blazar BR, Taylor PA, Smith S, Vallera DA. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts. Blood 1995; 85: 842.
32. Del Prete G, De Carli M, Almerigogna F, Gindizi MG, Biagotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353.
33. Rowbottom AW, Norton J, Riches PG, Hobbs JR, Powles RL, Sloane JP. Cytokine gene expression in skin and lymphoid organs in graft versus host disease. J Clin Pathol 1993; 46: 341.